Edenred SA EDEN

Edenred SE (EDNMF) reports robust intrinsic growth and strategic advancements despite regulatory impacts in key markets.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Edenred’s latest analyst update leaves the existing price target unchanged, giving you a steady reference point as you think about where the stock currently sits. With no fresh analyst commentary provided alongside this update, the focus is squarely on how the absence of change fits into the broader story. Read on to see how to track this evolving narrative and what to watch for in future revisions. Stay updated as the Fair Value for Edenred shifts by adding it to your watchlist or portfolio...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

EDENRED (EDNMY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Edenred SE (EDNMF) reports robust growth in EBITDA and free cash flow, despite facing regulatory impacts in Italy and Brazil.

XRAY, EDNMY and SLVM have been added to the Zacks Rank #5 (Strong Sell) List on Nov.11, 2025

Edenred (ENXTPA:EDEN) shares have seen some ups and downs over the past month, with the stock currently down 12% in that time. Investors are paying close attention to how these shifts might reflect broader market moves or company fundamentals. See our latest analysis for Edenred. While Edenred shares have experienced a sharp pullback recently, the bigger story is that this extends an ongoing slide. The share price is down 11.9% over the last month and total shareholder return shows a steep...